WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today financial results for its third fiscal quarter ended February 29, 2012.
Net sales increased 5% (5% constant currency) worldwide to $709 million
- Large joint reconstructive sales increased 5% (5% constant currency) worldwide and increased 6% in the U.S.
- Sports medicine sales increased 22% (22% constant currency) worldwide, with 18% U.S. growth
- Extremity sales grew 18% (18% constant currency) worldwide, with a 21% increase in the U.S.
- Operating cash flow of $158 million
- Binding offer to acquire DePuy trauma business for $280 million
